UNSPSC 51372304: Carperidine

This classification denotes an opioid receptor agonist, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier LZ6E4G9827. European Medicines Agency schedules Carperidine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06138MIG. Carperidine generally arises in the molecular formula C17H24N2O3.

UNSPSC 51372304 Carperidine is a Commodity code that does not align with the state and local contract opportunities posted under it. The code nominally refers to carperidine, a pharmaceutical active ingredient, yet the recent solicitations tagged to this code involve naloxone procurement, direct-to-manufacturer prescription programs, and multi-source generic pharmaceuticals and over-the-counter products—none of which are carperidine-specific. The mismatch suggests either a miscoding or data synchronization error in the state and local procurement system. State and local buyers do not appear to be soliciting carperidine itself under this code at present.

The three recent opportunities shown—Seminole County's naloxone and drug deactivation systems bid (IFB, due July 26, 2023), the Texas HHS Commission's Request for Information on direct-to-manufacturer prescriptions (RFI, due April 3, 2026), and the Minnesota Multistate Cooperative Purchasing Alliance's generic pharmaceuticals and OTC products RFP (RFP, due March 26, 2026)—reveal activity in Florida, Texas, and Minnesota, but none speak to carperidine as a procurement target. The code shows little relevant recent activity for a business development professional seeking to pursue carperidine supply contracts in the state and local market.